This episode opens with a distinction that matters more in lung cancer than many oncologists expect.
Around the Practice: From Testing to Treatment: A Multidisciplinary Approach to First-Line HER2/ERBB2-Mutant Non-Small Cell Lung Cancer
This episode takes up the practical mechanics of molecular testing in community oncology, beginning with turnaround time.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Ropeginterferon Alfa for Essential Thrombocytopenia
2
ASCO Issues First Living Guideline for Recurrent Ovarian Cancer Treatment
3
Botensilimab/Balstilimab Elicits Major Pathologic Responses in Colon Cancer
4
ADI-212 Receives FDA IND Clearance for Castration-Resistant Prostate Cancer
5